Efficacy and pharmacokinetics of adefovir dipivoxil liquid suspension in patients with chronic hepatitis B and renal impairment

Journal of Clinical Pharmacology

Volumn 51, Issue 9, 2011, Pages 1293-1301

  Shiffman, Mitchell L ^a   Pol, Stanislas ^b   Rostaing, Lionel ^c   Schiff, Eugene ^d   Thabut, Dominique ^e   Zeuzem, Stefan ^f   Zong, Jian ^g,h   Frederick, David ^g,h   Rousseau, Franck ^g,h  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f GOETHE UNIVERSITY   (Germany)

^g Gilead Sciences   (United States)

^h NONE

Author keywords

Biostatistics clinical trials; clinical pharmacology; clinical research; clinical trials; infectious diseases

Indexed keywords

ADEFOVIR DIPIVOXIL; ALANINE AMINOTRANSFERASE; BILIRUBIN; CREATININE; HEPATITIS B(E) ANTIGEN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY HEIGHT; BODY WEIGHT; CHRONIC HEPATITIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG DOSAGE FORM COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEADACHE; HEMODIALYSIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; LIQUID SUSPENSION; MALE; MAXIMUM PLASMA CONCENTRATION; MULTICENTER STUDY; NAUSEA; OPEN STUDY; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; UPPER ABDOMINAL PAIN;

ADENINE; ADULT; AGED; ANTIVIRAL AGENTS; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; PHARMACEUTICAL SOLUTIONS; PHOSPHONIC ACIDS; RENAL INSUFFICIENCY; TREATMENT OUTCOME;

EID: 80051760726     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270010381385     Document Type: Article

References (15)

1. McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis. 2005 ; 25 (suppl 1). 3-8 (Pubitemid 41254588)
2. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepatitis. 2004 ; 11: 97-107 (Pubitemid 38365759)
3. Marcellin P, Chang T-T, Lim SG, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med. 2003 ; 348: 808-816 (Pubitemid 36245757)
4. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med. 2003 ; 348: 800-807 (Pubitemid 36245756)
5. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology. 2006 ; 131: 1743-1751 (Pubitemid 44958517)
6. Schiff E, Lai CL, Hadziyannis S, et al. Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results. Liver Transplant. 2007 ; 13: 349-360 (Pubitemid 46444463)
7. Benhamou Y, Thibault V, Vig P, et al. Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1. J Hepatol. 2006 ; 44: 62-67 (Pubitemid 41772517)
8. US prescribing information [online].. 2008 ;:
9. Fabrizi F, Messa P, Martin P. Hepatitis B virus infection and the dialysis patient. Semin Dialysis. 2008 ; 21: 440-446
10. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976 ; 16: 31-41
11. Han SH. Extrahepatic manifestations of chronic hepatitis B. Clin Liver Dis. 2004 ; 8: 403-418
12. Pillai AA, Levitsky J. Overview of immunosuppression in liver transplantation. World J Gastroenterol. 2009 ; 15: 425-433
13. Hauser AB, Stinghen AE, Kato S, et al. Characteristics and causes of immune dysfunction related to uremia and dialysis. Periton Dialysis Int. 2008 ; 28 (suppl 3). S183 - S187
14. Angus PW, Patterson SJ, Strasser SI, et al. A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis. Hepatology. 2008 ; 48: 1460-1466
15. Fontaine H, Vallet-Pichard A, Chaix ML, et al. Efficacy and safety of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency. Transplantation. 2005 ; 80: 1086-1092 (Pubitemid 41611932)